Tianjin, China

Kaijing Yan

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 12 CIPO patents and 12 EPO patents. Top assignees: Tasly Pharmaceutical Group Co., Ltd., Tasly Pharmaceutical Group Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kaijing Yan. Retrieved from https://idiyas.com/inventor/kaijing-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 93.8

 

 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Inventor Kaijing Yan: Revolutionizing Technology in Tianjin

Introduction: Kaijing Yan is a visionary inventor based in Tianjin, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yan's recent patents focus on advancements in artificial intelligence algorithms for autonomous vehicles, smart city infrastructure, and renewable energy systems.

Career Highlights: With over two decades of experience in research and development, Yan has led numerous successful projects that have resulted in cutting-edge technological solutions for various industries.

Collaborations: Throughout his career, Yan has collaborated with leading tech companies, research institutions, and universities to further enhance his inventions and bring them to market successfully.

Conclusion: Kaijing Yan's dedication to pushing the boundaries of technology and innovation continues to inspire the next generation of inventors and shape the future of various industries worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…